Cyclophosphamide Therapy During the Covid19 Pandemic

Bitik, B.Oygur, C. S.Kanbur, A. YalcintasYucel, A. E.2024-04-032024-04-0320230003-4967https://ard.bmj.com/content/annrheumdis/82/Suppl_1/1879.3.full.pdfhttp://hdl.handle.net/11727/11997enginfo:eu-repo/semantics/openAccessVasculitisCOVIDBest practicesCyclophosphamide Therapy During the Covid19 PandemicconferenceObject82Supplement 1187918800011073987062661468-2060